Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04024423 · ClinicalTrials.gov registry record
Healthcare-associated Links in Transmission of Nontuberculous Mycobacteria in Cystic Fibrosis
A clinical trial, sponsored by National Jewish Health.
- Completed
- Registry status
- 100
- Enrollment target
NCT04024423 is a clinical trial that has completed, run by National Jewish Health. The registered enrollment target is 100 participants.
The verdict
NCT04024423 has completed, sponsored by National Jewish Health.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
Sources of NTM infection and modes of transmission among CF patients are poorly understood. Healthcare-associated transmission of NTM among CF patients has been suspected and is of growing concern for CF Centers. There is a need for a systematic evidence-based approach to investigating potential episodes of healthcare-associated transmission. Clusters of highly similar strains of NTM in CF patients cared for at the same CF Center may arise from healthcare sources including patient-to-patient transmission and/or acquisition from water sources within a healthcare setting. The primary objective of the study is to facilitate a standardized process by which CF Centers may perform data abstraction on patients identified with highly similar NTM isolates and determine if clustered NTM strains are related to strains isolated from healthcare setting water biofilm sources. HALT NTM is available to the entire CF Foundation Care Network, under a collaborative agreement, to initiate a standardized, independent, confidential, internal NTM outbreak investigation. Patients that are identified by whole genome sequencing as having highly similar NTM strains and receiving care in the same CF Care Center are eligible. The study's primary endpoint is to identify potential modes and sources of healthcare-associated acquisition of CF NTM, thereby revealing risk factors for NTM acquisition.
Interventions
- OTHER Epidemiologic investigation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2019-07-01 |
| Est. Completion | 2023-07-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04024423
The ClinicalTrials.gov registry entry for NCT04024423 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Jewish Health, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Epidemiologic investigation is the first listed.
NCT04024423 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04024423 about?
NCT04024423 is a clinical study titled "Healthcare-associated Links in Transmission of Nontuberculous Mycobacteria in Cystic Fibrosis". Sources of NTM infection and modes of transmission among CF patients are poorly understood. Healthcare-associated transmission of NTM among CF patients has been suspected and is of growing concern for CF Centers. There is a need for a systematic evidence-based approach to investigating potential epi...
What is the current status of trial NCT04024423?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2019-07-01. Estimated completion is 2023-07-01.
What interventions are being tested in trial NCT04024423?
The interventions under investigation include: Epidemiologic investigation (OTHER).
Who is sponsoring clinical trial NCT04024423?
This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.